Member Info for Compoundinterest

Thx for sharing MM. Your not talking to urself. Appreciate the sharing.

Solid results, Solid company, Solid pipeline. Nothing unexpected from the results, looking good. Surprised the trials expected to go ahead despite Covid-19 situations.

hope so... but i doubt it. This seller seems quite persistent to exit quickly.

Painful to watch this continue to slide. How much further when market cap is only 14m...

Hope so... however for the sake of playing devil's advocate, the 2bn sales are spread across many years does not mean much to the bottom line unless they can demonstrate net positive cashflows and net profit from those projects (some lose money). If Capita can generate quicker than paying off debt we would be closer to a dividends which is hopefully we will end up soon or later.

It looks like it. With the significant debt pile which ESS is not gonna come close to cover all of it. I think a raise could be good for this company in the long run.

Thanks Moneymunch, you share some real quality research and insights on this company! Gd stuff.

Yes fingers crossed we can see the TR1 seller soon.. the earlier the better then this SP can progress.

@Money Munch Great video. thanks for sharing. I am just sharing opinions on whats happening. Most of us are blind by whats happening in the background with the sellers so I think it's quite interesting to get other peoples opinions and perspectives other than ramp comments in forums. Hoping to also see comments from both sides of the story.

@Moneymuch - thanks for sharing. Great insights appreciate it. Although we have had great RNS and news from Evgen of late but it seems to have been overwhelmed by a wave of sells who is/are desperate to exit. To me, it's quite alarming and the risks of buying a falling knife now seems quite high. It's obvious a IIs or large PI are the culprit for the major selling since the recent buys on news by retail investors have hardly made any impact on share price movement upwards. This company has a lot in the pipeline and a lot of potential especially with:
1) Covid-19 recruitment of 100 patients due in next few months for ARDS.
2) New target SHP2 target as inhibitor. If SFX-01 proves effective at inhibiting SHP2 we could be hitting a gold pot.
3) NRF2 target
4) Juvenescence dietary supplement could be a cashcow for EVG. (We shall see.. upfront payment & commitments demonstrate the tech is legit.)

Timeline: I am looking for the right entry point to BUY shares in this exciting biotech but cautious to date due to the selling in the background; I think it might be wise to wait until the storm passes. Welcome suggestions?

Is this the end of the selling or just a short term pause? Over the past few months I suspect we have had a lot of background selling orders from the following guys below:
-Richard Griffiths from 10.86% to 8.92%
-SPREADEX LTD sold 8.29% to 3.87%.

Since no additional RNS has been issued yet for further reduction in holdings, I guess we will get one soon. If this is the case, there could be more selling to come? Only my suspicions, anyone else have other ideas.

I think the market already priced in an EBITDA loss of 2million already as stated in the Dec update, but the reality of seeing it on paper and losing the element of surprises just wasn't enough. This is a great stock and board. onwards and upwards! GLA

Gosh.. they market didn't take this well. End of the day, Eve is a much stronger company with solid foundation. I am a buyer at these levels. Thanks very much.

Looks like we have a relatively bigger seller in the background, at this rate expecting this to return to around closing price unfortunately.

Good news and a step in the right direction. Going forward, wud be great to receive upfront payments and milestones!

MMs making a fortune on these spreads despite increase in volume.

Equity Raise and SP increase that's a surprise for this stock.

@HH - these sound like reasonable projections. What are your forecasts for EBITDA? On the previous update CC mentioned projected loss of 2.1+ million; any back of the fag estimates extrapolated from December figures?

Eve Rising & Shining, onwards and upwards.

Some big trades going through in anticipation of RNS results day. Holding strong. Topping up when funds available.